C.M. Bidwell & Associates’s Esperion Therapeutics ESPR Stock Holding History

C.M. Bidwell & Associates’s Portfolio ESPR Stock Details ESPR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$795	Buy
2017 Q2	–	Sell
2017 Q1	$219K	Sell
2016 Q4	$201K	Hold
2016 Q3	$222K	Buy